A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11

Cancer Research

Volumn 61, Issue 13, 2001, Pages 5083-5089

  Meck, M M ^a   Wierdl, M ^a   Wagner, L M ^a   Burger, R A ^a   Guichard, S M ^a   Krull, E J ^a   Harris, L C ^a   Potter, P M ^a   Danks, M K ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLESTERASE; COMPLEMENTARY DNA; IRINOTECAN; PRODRUG; SYNAPTOPHYSIN; TYROSINE 3 MONOOXYGENASE;

ADENOVIRUS; ARTICLE; CYTOTOXICITY; DRUG EFFICACY; GENE TARGETING; GENE THERAPY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOTRANSFORMATION; BONE MARROW PURGING; CAMPTOTHECIN; CARBOXYLESTERASE; CARBOXYLIC ESTER HYDROLASES; DNA, COMPLEMENTARY; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; NEUROBLASTOMA; PRODRUGS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035392940     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Long-term survival in refractory recurrent neuroblastoma
2. Biology and genetics of human neuroblastomas
3. Advances in the diagnosis and treatment of neuroblastoma
4. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
5. D2 antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age
6. 131I MIBG therapy in neuroblastoma: Mechanisms, rationale, and current status
7. Current aspects of biology, risk assessment, and treatment of neuroblastoma
8. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells
9. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy
10. Autologous bone marrow transplantation in breast cancer: Separation of clonogenic tumor cell colonies by gradient fractionation
11. Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograft
12. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: A report from the Children's Cancer Group
13. Genetic prodrug activation therapy
14. Adenovirus vector-based purging of multiple myeloma cells
15. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation
16. A recombinant bcl-xs adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells
17. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources
18. Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11
19. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy
20. Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11
21. Cellular localization domains of a rabbit and a human carboxylesterase: Influence on CPT-11 metabolism by the rabbit enzyme
22. Efficacy of systemic administration of irinotecan against neuroblastoma xenografts
23. Direct translation of a protracted irinotecan schedule from a xenograft model to a Phase I trial in children
24. Histochemical staining following LacZ gene transfer underestimates transfection efficiency
25. Assays of hemopoietic progenitor cells
26. + late progenitors from enriched peripheral blood CD34+ cells
27. Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit carboxylesterase
28. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA
29. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus
30. Isolation and partial characterization of a carboxylesterase that converts CPT-11 to SN-38
31. Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro
32. Detection of metastatic neuroblastoma in bone marrow: When is routine marrow histology insensitive?
33. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads